Ragni discussed unique advantages fitusiran offers over other approved therapies for hemophilia A or B.
Margaret V. Ragni, MD, MPH
Advertisement
Articles by Margaret V. Ragni, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Odevixibat Fails to Improve Native Liver Survival in Phase 3 BOLD Trial for Biliary Atresia
2
Survey Reveals Low Awareness of Chronic Hepatitis B’s Link to Liver Cancer
3
Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment
4
Omalizumab Outperforms Multiallergen OIT for Multifood Allergy
5